Update on the Non-Pharmacological Management of Stroke Prevention in Patients with Atrial Fibrillation

Author： Tolat Aneesh   Lippman Neal  

Publisher： MDPI

E-ISSN： 2077-0383|7|2|32-32

ISSN： 2077-0383

Source： Journal of Clinical Medicine, Vol.7, Iss.2, 2018-02, pp. : 32-32

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Concerns Regarding the Use of Dabigatran for Stroke Prevention in Atrial Fibrillation

By Stöllberger Claudia   Finsterer Josef  

Pharmaceuticals, Vol. 5, Iss. 2, 2012-02 ,pp. : 155-168

MDPI

Access to resources Recommend Favorite

Stroke Prevention in Atrial Fibrillation: Latest Clinical Trials and Guidelines

By Armaganijan Luciana   Patel Dimpi   Dietrich Cristiano   Morillo Carlos A.  

Pharmaceuticals, Vol. 5, Iss. 4, 2012-04 ,pp. : 384-397

MDPI

Access to resources Recommend Favorite

Newer Anticoagulants for Non-Valvular Atrial Fibrillation

By Harburger Joseph M.   Aronow Wilbert S.  

Pharmaceuticals, Vol. 5, Iss. 5, 2012-05 ,pp. : 469-480

MDPI

Access to resources Recommend Favorite

Management of Stroke in Older People; A Pharmacological Perspective

By  

The Australian Journal of Hospital Pharmacy, Vol. 30, Iss. 2, 2000-04 ,pp. : 60-65

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Current Role of Omega-3 Fatty Acids in the Management of Atrial Fibrillation

By Christou Georgios A.   Christou Konstantinos A.   Korantzopoulos Panagiotis   Rizos Evangelos C.   Nikas Dimitrios N.   Goudevenos John A.  

International Journal of Molecular Sciences, Vol. 16, Iss. 9, 2015-09 ,pp. : 22870-22887

MDPI

Access to resources Recommend Favorite